Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bb66b43b5d80ebba7cb1a3fbfbe5badfc> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bb66b43b5d80ebba7cb1a3fbfbe5badfc NCIT_P378 "NCI" @default.
- Bb66b43b5d80ebba7cb1a3fbfbe5badfc type Axiom @default.
- Bb66b43b5d80ebba7cb1a3fbfbe5badfc annotatedProperty IAO_0000115 @default.
- Bb66b43b5d80ebba7cb1a3fbfbe5badfc annotatedSource NCIT_C171097 @default.
- Bb66b43b5d80ebba7cb1a3fbfbe5badfc annotatedTarget "A preparation of personalized tumor-derived T-lymphocytes composed of tumor infiltrating lymphocytes (TILs) that are reactive to clonal cancer neoantigens, with potential immunostimulating and antineoplastic activities. The TILs are removed from the suppressive tumor microenvironment (TME) and re-activated. Upon reintroduction into the patient, the clonal neoantigen T (cNeT) cells recognize and bind to tumor cells expressing the targeted neoantigen, resulting in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the patient's tumor cells." @default.